Clinical Trial

Assessment of Mean Fetal Kidney Length as a Reliable Parameter for Accurate Estimation of Gestational Age in Late 2nd and 3rd Trimesters

Completed
View on ClinicalTrials.gov →
Summary
Accurate GA estimation is necessary when early termination of pregnancy is necessary as soon as the fetus becomes mature e.g. cases of pre-eclampsia, chronic renal disease, severe intrauterine growth retardation (IUGR), diabetes and placenta praevia centralis. Accurate GA estimation is also necessary where certain tests need to be performed for example amniotic fluid and serum assays, chorionic villus sampling and to plan fetal therapies. (Gupta DP et al., 2013)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-20.
Status change: Recruiting → Completed 2026-02-27
Trial Details
NCT Number NCT07188324
Lead Sponsor Cairo University
Conditions Fetal Conditions
Enrollment 100 participants
Start Date 2024-07-21
Primary Completion 2026-01-21 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-02